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Snakebite admissions in Zimbabwe: Pattern, clinical presentation
and management
*D TAGWIREYI, * *CFB NHACHI, ***DE BALL
Abstract
Objective: To describe the toxicoepidemiology o f  snakebite admissions to eight major referral hospitals in 
Zimbabwe.
Design: Retrospective and descriptive case review.
Setting: Four central hospitals (i.e., Harare, Parirenyatwa, Mpilo and United Bulawayo Hospitals) and four 
provincial hospitals (i,e., Gwanda, Bindura, Gweru and Mutare hospitals).
M ain Outcome M easures: Parameters assessed for included patient demographics e.g. age and gender, 
length o f hospital stay, circumstances leading to snakebite, season and time o f  day o f  bite, culprit species, 
clinical presentation, management before and after admission, and outcome.
Results: There were a total o f 273 admissions due to snakebite. Over 60% o f bites were to the feet and about 
36% were to the arms and hands. The type o f  snake involved was recorded in 14.6% (40) the cases with puff 
adders (Bitis arietans) being the most commonly implicated species. First aid and other pre-hospital 
treatments were recorded in 38 cases with tourniquets employed in 24 cases (63.2%) and 13 patients visiting a 
traditional medical practitioner before going to hospital. There were similar proportions o f  males to females 
admitted with snakebite and the case fatality rate in this study was 2.9%.
Conclusion: Most bites from snakes in Zimbabwe occur to the feet and are probably from puff adders. The 
tomiquet appears to be the most commonly employed first aid measure for snakebite in Zimbabwe, and 
snakebite victims still consult traditional healers.
Cent A fr J M e d  2011; 57(5/8): 17-22
Introduction
Of the approximately 2500 species of snakes that are 
found throughout the world, less than 200 are 
venomous.' However, a larger proportion of venomous 
snakes and snakebite morbidity occurs in tropical and 
subtropical areas, often encompassing developing 
countries.2,3 To illustrate this, only one species of 
poisonous snake, the common European adder (Vipera
berus) is indigenous to Britain and accounts for about 
200 hospital admissions annually with only a handful 
of deaths in the last century (12 by 1993).4 On the other 
hand, the World Health Organisation estimates about 
one million snakebites on the African continent alone 
involving 500 000 envenomations with 40% being 
hospitalised.5 and it has been estimated that snakebite 
causes about 100 deaths per day in India and Pakistan.3 
However, there remains a paucity of reliable data on the
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prevalence, incidence, morbidity and mortality of 
snakebite in developing countries.56 In Zimbabwe, 
animal envenomation, in particular snakebite, has been 
identified as the fourth most important cause of 
hospital admissions to major referral hospitals due to 
toxic exposures after poisoning with pesticides, 
pharmaceuticals and household chemicals.7 O f the 
approximately 76 species of snakes, belonging to seven 
families, that are found in Zimbabwe, only about 19 
species are of medical importance with respect to 
envenomation.89 These venomous snakes fall into four 
broad families, which are the Elapids (Elapidae), 
Vipers (Viperidae), Colubrids (Colubridae) and the 
African burrowing asps (Actractaspis) and have been 
extensively discussed elsewhere.9 In the present work, 
the most extensive account of snakebite admissions to 
Zimbabwean health facilities, the pattern, and clinical 
presentation of snakebite in Zimbabwe is presented 
based on a retrospective survey of all cases of snakebite 
admitted to eight major referral hospitals in the country.
M aterials and M ethods
The methods have been reported previously.7 
Retrospective case reviews were conducted at all 
Central Hospitals (Parirenyatwa, Harare Central, 
Mpilo and United Bulawayo Hospitals) and four of the 
seven Provincial Hospitals (Bindura, Mutare, Gweru 
and Gwanda Hospitals) for the period January 1998 - 
December 1999 inclusive. Data from Harare Hospital 
was incomplete for the months September and October, 
1999 due to inadvertent deletion of records from the 
Record Department computer. Permission to conduct 
the study was granted by the Medical Superintendents 
of the respective hospitals, the Ethics Committee for 
Mpilo Hospital, and the Medical Research Council of 
Zimbabwe.
Retrieval of data.
The methods used in retrieving the case records varied 
from hospital to hospital, usually tracing records using 
relevant ICD-9 codes, then retrieving patients notes 
from the hospitals' record departments or, in the case of 
Bindura and Gweru hospitals, patient case notes were 
traced through hospital medical ward registers and the 
patient code used to retrieve the records from the 
Records Department.
Analysis of data.
Data extracted from case records included patient 
demographics e.g. age and gender, length of hospital 
stay, circumstances leading to snakebite, season and 
time o f day o f bite, culprit species, clinical 
presentation, management and c utcome.
In order to give a clear picture o f the clinical 
p resen tation  o f  snakebite  ra ther than later 
complications, only cases of 'acute snakebite' were 
used with presentation to the hospital on the day of or 
that immediately following the bite. Patients
presenting a day after the bite were included since most 
snakebites in Zimbabwe occur in the later hours of the 
day8 and patients may only receive medical attention 
the following day. Cases where the date of the 
snakebite was not noted in the records were also 
excluded. In addition, all patients with co-existing 
illnesses were excluded from description of the drug 
management to prevent contamination with co­
administered medicines.
Results
There were a total of 273 admissions due to snakebite, 
of which the type of snakes involved in the bites was 
recorded in 14.6% (40) of these. Puff adders were the 
most commonly implicated snake species (62.5%; 25) 
followed by cobras (22.5%; one Egyptian cobra [Naja 
haje]) and mambas (12.5%; one green mamba 
[Dendroaspis angusticeps] with the rest black mambas 
[.Dendroaspis polylepis]). There was also a case of 
snakebite due to a burrowing asp (Atractaspis spp.), the 
only case where identification was made by a 
herpetologist.
Patient demographic details.
Similar proportions of males and females were 
admitted to hospital with snakebite (1:1; n=271) 
regardless of age group.
Figure I: Age-sex distribution o f  admissions due to 
snakebite to the study hospitals (n=268 cases).
Age (yrs)
Bite circumstances and fir s t aid
Most admissions (over 80%) occurred during the 
summer, wetter months of November to April, peaking 
in January (17.9%) (Figure 2). Where time of day was 
recorded (157 cases), most bites (68.1%) occurred 
between 18:00 and 24:00. The snakebite site was 
recorded in 224 cases with most bites to feet (61.2%), 
hands (19.2%) and arms (16.5%). First aid and other 
pre-hospital treatments were recorded in 38 cases with 
tourniquets employed in 24 cases (63.2%) and 13 
patients (34.2%) visited a traditional medical 
practitioner before going to hospital. Other treatments 
included incision of the bite site with or without oral 
suction of the blood (5 cases) and washing of the bite 
site with soap and water (1 case).
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Figurell: Seasonal d istribu tion  o f  snakebite  
admissionsfor 1998-1999 (n=273).
Acute snakebite.
A total of 193 cases (70.7% of all snakebite admissions) 
met the inclusion criteria for 'acute snakebite1. Of the 
60 excluded cases, the bite date was not recorded in 36, 
whilst in the remainder the patients presented two days 
or more after the snakebite. The patient demographic 
details for acute snakebite admissions were similar to 
those for all cases.
Data on clinical presentation was available for all but 
one case. Most patients (116 cases) suffered only local 
signs of snakebite of which swelling and local pain 
were most prominent. About a third (31.8%; 61) had 
systemic signs and symptoms e.g., vomiting and 
dizziness, with or without local signs (Table 1). In 15 
cases (7.8%) there were no clinical signs or symptoms 
of envenomation. Bites attributed to puff adders (Bids 
spp.; 17) displayed almost exclusively localised 
symptoms especially swelling. Swelling also occurred 
in six of the seven bites attributed to cobras (Naja spp.) 
with two patients presenting with dyspnoea. Ptosis and 
pain at the bite site each occurred in two of the five 
patients with mamba (Dendroaspis spp.) bites. The 
burrowing asp (Atractaspis spp.) bite was on the finger 
with the patient presenting with pain and a swollen 
hand.
Table I: Presenting signs and symptoms o f  snakebite: 
a) Common local symptoms o f  snakebite in Zimbabwe.
Symptom Number(%)of cases
(n=193)
S w e l l in g 1 4 1 ( 7 3 .4 )
L o c a l  p a in 7 0 ( 3 6 .5 )
T e n d e r n e s s  a t  b i te 5 5 ( 2 8 .6 )
W a rm th  a t  b i t e  s i te 2 2 ( 1 1 .5 )
N u m b n e s s  a t  b i t e  s i te 1 2 (6 .2 )
M in o r  b le e d in g  f ro m  b ite  s i te 6 ( 1 .6 )
Table I: Presenting signs and symptoms o f  snakebite: 
b) Common systemic signs associated with snakebite in 
Zimbabwe.
Systemic signs and symptoms N umber (%) of cases
(n=193)
V o m it in g  w i th  o r  w i th o u t  b lo o d 1 3 ( 6 .8 )
D iz z in e s s 1 1 ( 5 .7 )
H e a d a c h e 8 ( 4 .2 )
P y re x ia 8 ( 4 .2 )
S w e a t in g 6 ( 3 .1 )
A b d o m in a l  p a in s 5 ( 2 .6 )
R e s t le s s n e s s 4 ( 2 .1 )
G e n e r a l  b o d y  w e a k n e s s 3 ( 1 .6 )
G e n e r a l  b o d y  p a in s 3 ( 1 .6 )
Drug treatment o f  acute snakebite.
Twelve of the 193 cases of acute snakebite involved 
patients with co-existing illness and were excluded
from the analysis. In the remaining 181 cases,
antibiotics were the most commonly used therapeutic 
intervention with 147 cases (77.3%) receiving at least 
one antibiotic. Antitetanus toxoid and analgesics were 
also used in a large proportion of the patients (52.5% 
each) (Table II), with paracetamol-containing
analgesics commonly used. Opiate analgesics were
not used in cases attributed to neurotoxic elapids.
Other important drug therapies included systemic 
corticosteroids, antihistamines and non-steroidal anti­
inflammatory drugs (NSAIDs) (Table II). Only 6 cases
received polyvalent snake antivenom, with two
patients not receiving any specific drug therapy.
Table II: Medicines used in 
snakebite.
management o f  acute
Drug class Number(%)of cases
(n=181)
A n tib io t ic s 1 4 0 ( 7 7 .3 2 )
A n t i t e ta n u s  to x o id 9 5 ( 5 2 .5 )
A n a lg e s ic s 9 5 ( 5 2 .5 )
S y s te m ic  c o r t ic o s te o id s 5 9 ( 3 2 .6 )
A n t ih i s t a m in e s 4 6 ( 2 5 .4 )
N S A I D s 4 3 ( 2 3 .2 )
I n t r a v e n o u s  f lu id s 2 1 ( 1 1 .6 )
O th e r d r u g s 1 7 ( 9 .4 )
S n a k e  a n t iv e n in 6 ( 3 .3 )
N o  s p e c i f ic  d r u g  th e r a p y 2 ( 1 .1 )
Discussion
Whilst snakebite continues to be of major concern in 
most developing countries, some researchers have 
cited a lack of reliable data on the prevalence, 
incidence, morbidity and mortality of snakebite in 
these regions.56 This retrospective survey of eight 
major referral hospitals in Zimbabwe attempts to 
provide some meaningful clinicoepidemiological data 
with regards to snakebite in the Southern African 
region and in Zimbabwe in particular.
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Studies from elsewhere have reported on gender 
differences in the proportions of snakebite victims.210 
In this study, snakebite involved males and females 
equally. Differences in gender ratios o f patients 
adm itted  w ith snakebite  often  resu lt from 
predispositions arising from occupational and/or 
cultural activities related to gender. For example, most 
bites from foreign venomous snakes in the Us1 and the 
UK10 occur in males since there are more male than 
female snake handlers and males engage more in risk­
taking behaviour. However, in various indigenous 
groups in Ecuador, females take more active roles in 
crop planting and are thus at a higher risk o f snakebite.2 
The present study and o ther studies from 
Zimbabwe81" 2 have shown no gender differences in 
snakebite hospital admissions. It has been suggested 
that females are more prone to snakebite in Zimbabwe 
since they work in the fields, fetch firewood and water 
from the bush.13 However, whilst this may be true for 
the rural areas, the same cannot be said for urban and 
peri-urban areas where this and the other studies8 '112 
were conducted. Differences in gender distribution of 
snakebite admissions have however been reported at 
Triangle hospital in Zimbabwe, where the male to 
female ratio was 1.75:1.14 This was attributed to the 
higher male workforce population at the sugar 
plantation where most of the bites occurred.
Most cases of snakebite occurred in the first four 
decades of life in line with other published data from 
Zimbabwe.81112 and elsewhere.1516 This is the active age 
group who hence have higher chances of encountering 
snakes than the older and less mobile. Supporting 
other published literature for Zimbabwe,8'11'12 fewer 
snakebites occurred in the winter months of June and 
July when snake activity is low because most snakes 
are hibernating9 with the majority occurring in the rainy 
summer months.
A prospective 3-year study in Malaysia reported that 
snakebite was mainly an occupational hazard with 
most bites occurring during daylight, when more 
people are at risk.6 However, this was not the case in 
this study. Other Zimbabwean studies81213 also found 
that most of the bites occurred after daylight. This 
pattern suggests that snakebite in urban and peri-urban 
Zimbabwe is not related to occupational farming 
activities. The most hazardous time for snakebite in 
Africa is the half hour before total darkness and the first 
two hours after dark, when night snakes emerge and are 
active on the ground.9 This coincides with the time 
when workers are returning home or are going to their 
night shifts. However, since the exact activities 
involved were not recorded in the bulk of cases, a 
prospective study would be needed to confirm this.
Studies at Mpilo8 and Triangle14 hospitals in 
Zimbabwe, found most snake bites were to the lower 
limbs especially the feet. The same held true in the 
present study where over 60% of all the bites were to 
the feet. These results support an earlier suggestion 
that most bites occur whilst walking. One can also use 
the data to postulate on the species responsible for most
snakebites in Zimbabwe using a similar approach to 
that proposed for spider bites in Australia.17 The bite 
site pattern suggests that bites from mambas and cobras 
are not that common since these snakes generally tend 
to bite higher on the leg. Bites to the feet could result 
from puff adders or less venomous species such as the 
garter snake (Elopsoidae), snouted night adder 
(Causus defilippi) and rhombic night adder (Causus 
rhombeatus) which cause only local symptoms of pain 
and swelling.9 In addition, bites to the feet suggest a 
favourable prognosis since, theoretically, it would take 
longer for the venom to have systemic effects and 
become life-threatening. The foot as the most 
commonly encountered bite site also provides a good 
opportunity for preventative measures aimed at 
educating the populace on the importance of wearing 
closed shoes, particularly whilst walking at night in 
areas where snakebite is common, especially in the 
summer months.
In those cases where pre-hospital management was 
recorded, tourniquets were commonly used. Although 
there remains some debate, it is generally agreed that 
tourniquets should not be applied after bites from 
cytotoxic snakes such as the puff adder,9 since 
concentration of the venom in a small area will cause 
severe tissue damage. However, for bites from the 
neurotoxic mambas and cobras it has been argued that 
this may be the best treatment.1819 However, expecting 
a lay person to distinguish between snakes with 
neurotoxic or cytotoxic venom may not be practical. 
Pressure bandaging has been widely advocated based 
on experiments by Sutherland and colleagues20,21 on 
venomous Australian snakes. However, this method 
assumes that all snake venoms use the lymphatic 
system for distribution, and has been received with 
scepticism in Southern Africa where potentially lethal 
neurotoxic snakes such as the black mamba and cape 
cobra abound.22 Moreover according to a recent World 
Health Organisation publication19 this techniques has 
been described as demanding “special equipment and 
training and is not considered practicable for general 
use in Africa.” However, whether such an approach is 
appropriate in this context may still require local 
studies.
A number of patients in the current work visited a 
traditional practitioner before presenting to the 
hospital. In South Africa, Newman and colleagues23 
reported that 90% of all snakebite victims presenting to 
a hospital in kwaZulu-Natal had used some form of 
traditional remedy prior to admission. However very 
little is known or documented about the types of 
traditional medicines and remedies that are employed 
by traditional healers in Zimbabwe, although some 
plant preparations have been reported as being used.24 
A prospective study such as that done by Newman and 
co-workers23 in South Africa would therefore be useful 
in filling this gap of knowledge in Zimbabwe.
The fact that the bulk of the admitted cases of acute 
snakebite exhibited only local symptoms suggests that 
most cases involved less venomous snakes such as
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garter snakes and night adders, although in cases of 
bites by very venomous snakes, only sublethal doses of 
the venom could have been injected into the victim. 
This is demonstrated by the cobra and black mamba 
cases, snakes which are generally well-known and 
have easily identifiable features and thus could be 
assumed to be identified with some degree of certainty 
by the layman. Of the systemic signs and symptoms 
that were present, most could have been as a result of 
adrenaline release due to anxiety and fear. These 
would include vomiting, dizziness and sweating. 
However other symptoms such as dyspnoea and ptosis 
as well as joint pains were most likely the result o f true 
systemic envenomation. As a general rule, if systemic 
symptoms persist after 30 minutes then they are likely 
to be the result of the venom.25 Since it was difficult to 
elucidate any spatial relationships, it was not possible 
to correlate the observed symptoms to systemic 
envenomation in this study.
Despite the existence of data on the venomous snakes 
found in Zimbabwe'114 and Southern Africa,9 the culprit 
snake responsible for the bite in most admissions to 
hospitals in Zimbabwe is seldom known.8 In most 
cases, the bite victims do not recognise or see the snake 
(especially at night), let alone kill and present it for 
identification. This problem has been reported 
elsewhere in the world.26 In this study, the identity of 
the snake involved was recorded in 14.6% of the 
admissions, a lower proportion than that reported for 
Mplio Hospital in Zimbabwe (26.5%) over a two and a 
half year period.8 However, it is important to note that 
in most cases of snakebite, the identity o f the culprit 
snake is based on the patient's, companion's or doctor's 
report and seldom on expert herpetological advice. 
N evertheless, some species o f snakes with 
characteristic behaviours such as the puff adder (Bitis 
arietans), the cobras (Naja spp.) and the black mamba 
(Dendroaspis polylepis) are relatively well-known by 
Zimbabweans and hence chances that an ordinary 
citizen would be able to identify them are greater.
Drug therapy o f  snakebite.
In line with other studies of snakebite in Zimbabwe,813 
an tib io tics  w ere the m ost com m only used 
pharmacological intervention. Antitetanus toxoid was 
also extensively used and is recommended in the 
treatment of all cases of snakebite in Zimbabwe 
according to the national guidelines.27 Analgesics 
were also used in more than half of the cases and are 
also widely recommended for pain resulting from 
snakebite except in the case of neurotoxic bites where 
opioid analgesics should be avoided.28 In this study, 
opioid analgesics were not used in cases associated 
with bites from the neurotoxic elapids or with serious 
signs of neurotoxicity suggesting that physicians at the 
major referral hospitals in Zimbabwe are aware of the 
dangers of using these drugs in neurotoxic snakebite.
Systemic corticosteroids were also widely used, 
probably as an aid to reduce the inflammation arising 
from the snakebite. The use of these drugs has been
advocated in thdpast for the management of cobra29 and 
mamba bites,30 supposedly to alleviate the neurotoxic 
effects, as well as for viper bites.31 However, their role 
in the management of snakebite has not been reviewed 
or evaluated and hence it is difficult to comment on 
their use in this study. Non-steroidal anti­
inflammatory drugs were probably justified since they 
may reduce pyrexia that may result from snakebite14 as 
well as provide analgesia and anti-inflammatory 
activity.
Snake antivenin is the only effective and specific 
antidote for snakebite and is strongly recommended for 
venomous bites which have led to systemic toxicity.32 
However, only six patients received antiveriinin this 
series. This may show the relatively non-serious 
nature of most of the snakebite cases, but may reflect a 
poor availability at some of the hospitals. In two cases 
where antivenin was ordered by the physician, it was 
not available from the hospital pharmacy. Both 
patients survived on simple supportive therapy. In 
addition, due to the anaphylactic reactions that are 
associated with antivenin, physicians may be reluctant 
to employ this therapy even in cases where it would be 
lifesaving. In this study, none of the five deceased 
cases received any antivenin. A study to investigate the 
availability and perceptions toward the use of snake 
antivenin is necessary to determine the reasons for this 
low antivenin use.
The case fatality rate (CFR) in this study was 2.9% 
which was lower than the 5% reported by Muguti etal,8 
for Mpilo hospital but higher than the 1.8% reported in 
two earlier studies in Zimbabwe1213 and the 0.4% 
reported by Blaylock14 for a hospital in Triangle. The 
differences in CFR may be related to antivenin use. 
Whilst antivenin was used in 3.1 % of all cases of acute 
snakebite and 2.2% of all admitted cases in this series, 
there was no antivenin present at Mpilo hospital at the 
time Muguti8 and colleagues conducted their study and 
antivenin use was higher in the previous studies by 
Kasilo and Nhachi12 (21.2% and 32.5%). However, 
antivenin use in the study by Blaylock (3.6%) was 
comparable to that of this study a CFR of only 0.4% 
was reported. This may reflect inherent variability with 
Blaylock's work which was based at a single hospital 
whilst the present work is based on data from eight 
different hospitals countrywide.
While hospital presentation of snakebite has been 
examined previously in Zimbabwe, the present study is 
the most comprehensive across levels of hospital care 
and provides an updated clinicoepidemiological 
picture of snakebite in Zimbabwe. This provides a basis 
for studies looking at more indepth issues of snakebite, 
not only in Zimbabwe, but elsewhere.
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